Peripheral Nerve Injections and Procedures for Chronic Pain Final LCD - Effective November 1, 2026

Date Posted: September 17, 2026

This Local Coverage Determination (LCD) has completed the Open Public Meeting and Contractor Advisory Committee (CAC) comment period and is now finalized under contractor numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY). Responses to comments received may be found as a link at the bottom of the final LCD.

Medicare Coverage Database (MCD) Number/Contractor Determination Number: L40265

LCD Title: Peripheral Nerve Injections and Procedures for Chronic Pain

Effective Date: November 1, 2026

Summary of LCD: This LCD outlines limited coverage for this service and was developed to update existing policy to evidence based and incorporate new procedures and literature. Peripheral nerve injections (PNIs) consist of injections of local anesthetics (LA), with or without adjuvant steroids, into the perineural region of peripheral nerves or nerve ganglia. PNIs when used for chronic pain, are for the treatment and management of localized pain syndromes. PNIs provide targeted diagnostic or therapeutic benefits that generate temporary to long-term analgesic relief of chronic neuropathic pain or focal chronic nociceptive pain. Peripheral nerve denervation is the mechanical loss or interruption of nerve supply to muscle, organ or tissue, and can be used therapeutically to destroy nerves as a modality to treat chronic pain.

Visit the Proposed LCDs webpage to access this LCD.

Last Updated Sep 17 , 2026